The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1336
April 19, 2010
View Complete Issue         Table of Contents 2019 
Issue 1336
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Dutasteride (Avodart) for Prevention of Prostate Cancer
April 19, 2010 (Issue: 1336)
A study recently published in the New England Journal of Medicine concluded that dutasteride (Avodart – GlaxoSmithKline), a 5α-reductase inhibitor marketed for treatment of symptomatic benign prostatic hyperplasia, reduced the risk of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1336
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.